Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia Gravis
Condition: Myasthenia Gravis Intervention: Drug: CD19 CAR-T cells injection Sponsor: Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Myasthenia Gravis | Research